{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:32:30Z","timestamp":1789709550935,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":274,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1111\/jth.15320","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T11:38:06Z","timestamp":1616931486000},"page":"1776-1782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Antiprothrombin antibodies induce platelet activation: A possible explanation for anti\u2010FXa therapy failure in patients with antiphospholipid syndrome?"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3192-2457","authenticated-orcid":false,"given":"Walid","family":"Chayoua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4843-2975","authenticated-orcid":false,"given":"Phillip L.R.","family":"Nicolson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost C.M.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5025-9454","authenticated-orcid":false,"given":"Caroline","family":"Kardeby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Garcia\u2010Quintanilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7559-2579","authenticated-orcid":false,"given":"Katrien M.J.","family":"Devreese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"de Laat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7846-7423","authenticated-orcid":false,"given":"Stephen P.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15320_bb0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15320_bb0015","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/jth.15320_bb0020","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high\u2010risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"key":"10.1111\/jth.15320_bb0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/M19-0291","article-title":"Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial","volume":"10","author":"Ordi\u2010Ros","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.15320_bb0030","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/jth.14935","article-title":"Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Zuily","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15320_bb0035","first-page":"785","article-title":"Thrombosis and platelets: an update","volume":"11","author":"Koupenova","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.15320_bb0040","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/j.1538-7836.2008.03021.x","article-title":"Platelet activation by dimeric \u03b22\u2010glycoprotein I requires signaling via both glycoprotein Ib\u03b1 and apolipoprotein E receptor 2\u2032","volume":"6","author":"Urbanus","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15320_bb0045","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/art.21968","article-title":"Anti\u2013\u03b22\u2010glycoprotein I antibodies in complex with \u03b22\u2010glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib\u2010IX\u2010V","volume":"54","author":"Shi","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.15320_bb0050","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.3389\/fimmu.2018.02971","article-title":"Prevalence and significance of non\u2010conventional antiphospholipid antibodies in patients with clinical APS criteria","volume":"9","author":"Litvinova","year":"2018","journal-title":"Front Immunol"},{"key":"10.1111\/jth.15320_bb0055","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1160\/TH13-06-0509","article-title":"Antiprothrombin (aPT) and anti\u2010phosphatidylserine\/prothrombin (aPS\/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome: a systematic review","volume":"111","author":"Sciascia","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15320_bb0060","first-page":"635","article-title":"Warfarin therapy: evolving strategies in anticoagulation","volume":"59","author":"Horton","year":"1999","journal-title":"Am Fam Physician"},{"key":"10.1111\/jth.15320_bb0065","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/blood-2013-11-540526","article-title":"Amplification of bacteria\u2010induced platelet activation is triggered by Fc\u03b3RIIA, integrin \u03b1IIb\u03b23, and platelet factor 4","volume":"123","author":"Arman","year":"2014","journal-title":"Blood"},{"issue":"Suppl","key":"10.1111\/jth.15320_bb0070","first-page":"65","article-title":"Some murine monoclonal antibodies against human prothrombin have lupus anticoagulant activity","author":"Arnout","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15320_bb0075","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1055\/s-0037-1616090","article-title":"Quantification of lupus anticoagulants in clinical samples using anti\u2010 \u03b22GP1 and antiprothrombin monoclonal antibodies","volume":"86","author":"Querrec","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15320_bb0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1111\/jth.15320_bb0085","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3324\/haematol.2018.193391","article-title":"Inhibition of Btk by Btk\u2010specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI","volume":"103","author":"Nicolson","year":"2018","journal-title":"Haematologica"},{"key":"10.1111\/jth.15320_bb0090","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the scientific and standardization committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15320_bb0095","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MBC.0000000000000486","article-title":"Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients","volume":"27","author":"Moore","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.15320_bb0100","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.12364","article-title":"The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies","volume":"93","author":"Membre","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/jth.15320_bb0105","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/bloodadvances.2019030932","article-title":"Discovery and characterization of 2 novel subpopulations of aPS\/PT antibodies in patients at high risk of thrombosis","volume":"3","author":"Chinnaraj","year":"2019","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15320_bb0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1076029611412360","article-title":"Effects of antiphospholipid antibodies on in vitro platelet aggregation","volume":"18","author":"Palatinus","year":"2012","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/jth.15320_bb0115","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/MOH.0000000000000273","article-title":"Management of heparin\u2010induced thrombocytopenia","volume":"23","author":"Warkentin","year":"2016","journal-title":"Curr Opin Hematol"},{"issue":"Suppl 1","key":"10.1111\/jth.15320_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ijlh.12507","article-title":"Laboratory testing for antiphospholipid syndrome","volume":"38","author":"Pengo","year":"2016","journal-title":"Int J Lab Hematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15320","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15320","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622018062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622018062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:31:23Z","timestamp":1761535883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622018062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1538783622018062"],"URL":"https:\/\/doi.org\/10.1111\/jth.15320","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiprothrombin antibodies induce platelet activation: A possible explanation for anti\u2010FXa therapy failure in patients with antiphospholipid syndrome?","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}